Nan Su

Title: Nan Su: Innovator in Biomedicine

Introduction

Nan Su is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of biomedicine, particularly in the development of pharmaceutical compositions for cancer treatment. His innovative work has the potential to impact the lives of many patients suffering from various types of cancer.

Latest Patents

Nan Su holds a patent for a combined pharmaceutical composition aimed at treating tumors. This composition is specifically designed for biliary tract tumors, liver cancer, triple negative breast cancer, and lung cancer. The formulation includes an anti-PD-L1 antibody and anlotinib, demonstrating effective anti-cancer activity. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Nan Su has worked with notable companies in the pharmaceutical industry. He has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Nanjing Shunxin Pharmaceuticals Co., Ltd., both of which are part of the Chiatai Tianqing Pharmaceutical Group. His experience in these organizations has allowed him to collaborate with other experts in the field.

Collaborations

Nan Su has worked alongside talented individuals such as Xiquan Zhang and Xunqiang Wang. These collaborations have contributed to the development of innovative solutions in cancer treatment.

Conclusion

Nan Su's work in biomedicine exemplifies the importance of innovation in the fight against cancer. His contributions through patents and collaborations highlight his dedication to improving patient outcomes.